BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15301725)

  • 1. [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].
    Peng ZM; Luo J; Wang WB; Wang XH; Chen JH; Lan SM
    Ai Zheng; 2004 Aug; 23(8):963-7. PubMed ID: 15301725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
    Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
    Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.
    Hu WQ; Peng CW; Li Y
    J Exp Clin Cancer Res; 2009 Nov; 28(1):144. PubMed ID: 19930704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.
    Dingemans AM; van Ark-Otte J; van der Valk P; Apolinario RM; Scheper RJ; Postmus PE; Giaccone G
    Ann Oncol; 1996 Aug; 7(6):625-30. PubMed ID: 8879378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
    Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):304-7. PubMed ID: 11778556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
    Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
    Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy.
    Li XQ; Li J; Shi SB; Chen P; Yu LC; Bao QL
    Int J Biol Markers; 2009; 24(4):230-7. PubMed ID: 20082278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.
    Qiu ZQ; Zhao K
    Asian Pac J Cancer Prev; 2014; 15(17):7303-7. PubMed ID: 25227833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
    Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
    Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential overexpression of LRP and MRP but not P-gp 170 in VP16-selected A549 adenocarcinoma cells.
    Trussardi A; Poitevin G; Gorisse MC; Faroux MJ; Bobichon H; Delvincourt C; Jardillier JC
    Int J Oncol; 1998 Sep; 13(3):543-8. PubMed ID: 9683791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
    Boudaya MS; Smadhi H; Marghli A; Charmiti F; Ouerghi S; Mohamed J; Brahem E; Smati B; Mestiri T; Kilani T
    Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):432-6. PubMed ID: 24570525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung resistance protein and multidrug resistance protein in non-small cell lung cancer and their clinical significance.
    Chen ZJ; Le HB; Zhang YK; Qian LY; Sekhar KR; Li WD
    J Int Med Res; 2011; 39(5):1693-700. PubMed ID: 22117969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
    Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
    León L; Cueva-Banuelos JF; Huidobro G; Fírvida JL; Amenedo M; Lázaro M; Romero C; Estévez SV; Barón FJ; Grande C; García Mata J; González A; Castellanos J; Gómez A; Caeiro M; Rodríguez MR; Casal J;
    Lung Cancer; 2003 May; 40(2):215-20. PubMed ID: 12711124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.